Post by
StockDoctor101on Oct 21, 2022 12:25pm
Lots to look out for with AGN in Q4 and throughout 2023 - the phase 1 DMT human stroke study is planned for Q4. Also, the company recently announced Dr. Rick Strassman will be joining CEO Christopher
...more